Immune Effector Cell-associated Neurotoxicity Syndrome
15 drugs4,444 FAERS reportsMedDRA PT
GET
/api/v1/reaction/immune-effector-cell-associated-neurotoxicity-syndromeReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Immune Effector Cell-associated Neurotoxicity Syndrome (15)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Tarlatamab343%
- 2Axicabtagene Ciloleucel1,98121%
- 3Lisocabtagene Maraleucel14718%
- 4Obecabtagene Autoleucel517%
- 5Idecabtagene Vicleucel18916%
- 6Tisagenlecleucel4419.9%
- 7Teclistamab1829.3%
- 8Talquetamab1488.1%
- 9Epcoritamab938.0%
- 10Siltuximab427.0%
- 11Ciltacabtagene Autoleucel2905.7%
- 12Elranatamab475.3%
- 13Glofitamab1014.9%
- 14Brexucabtagene Autoleucel573—
- 15Blinatumomab202—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Neurotoxicity9 shared · 0.50
- Cytokine Release Syndrome15 shared · 0.42
- Hypogammaglobulinaemia6 shared · 0.38
- Diffuse Large B-cell Lymphoma4 shared · 0.21
- Acute Lymphocytic Leukaemia Recurrent3 shared · 0.18
- Cytopenia4 shared · 0.16
- Plasma Cell Myeloma5 shared · 0.15
- Aphasia3 shared · 0.14
- Haemophagocytic Lymphohistiocytosis2 shared · 0.12
- Diffuse Large B-cell Lymphoma Recurrent2 shared · 0.11
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.